← All indications
Tobacco Use Disorder
Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.
Drugs by status
Phase 4 trials (6)
Phase 3 trials (8)
Phase 2 trials (49)
- i-123-5-ia85380
- pozanicline
- lorcaserin
- ketamine
- clavulanate
- cotinine fumarate
- encenicline
- selegiline
- cannabidiol
- galantamine
- folic acid
- gemfibrozil
- gsk598809
- gw 468816
- hypericum perforatum
- labetalol
- memantine
- metyrapone
- moclobemide
- nic002
- niacin
- nicvax
- oxazepam
- phenethyl isothiocyanate
- azd8529
- aluminum hydroxide
- prazosin
- ramelteon
- celecoxib
- sirolimus
- +19 more
Phase 1 trials (16)
Organizations
Organization Involved with Phase 4 Indications (60)
- McNeil
- AstraZeneca
- Pfizer
- Sunovion
- Veterans Medical Research Foundation
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute on Drug Abuse (NIDA)
- University of Pennsylvania
- University of Pittsburgh
- Arizona State University
- Harvard University
- Dean Health System
- Temple University
- Johns Hopkins University
- Medical University Innsbruck
- New York University
- Northwestern University
- Rutgers University
- Southern Illinois University
- Stanford University
- Universidade Estadual de Londrina
- Universidade Estadual de Maringá
- University of Maryland
- University of Nevada, Reno
- University of South Carolina
- University of Southern California
- University of Toronto
- +30 more
Organization Involved with Phase 3 Indications (21)
- Research Foundation for Mental Hygiene, Inc.
- French National Agency for Research on AIDS and Viral Hepatitis
- National Center for Research Resources (NCRR)
- University of Arizona
- Brown University
- University of London
- Duke University
- University of Iowa
- University of Ottawa
- University of Adelaide
- University of Bordeaux
- University of Virginia
- Mayo Clinic
- University of Copenhagen
- University of Minnesota
- University of Sao Paulo
- University of Alabama, Birmingham
- Canadian Cancer Society
- Pharmavite
- Philip Morris
- Danish Research Foundation, Copenhagen
Organization Involved with Phase 2 Indications (36)
- Novo Nordisk
- Novartis
- Axsome Therapeutics, Inc.
- FORUM Pharmaceuticals Inc
- Nabi Biopharmaceuticals
- Omeros Corporation
- Orexigen Therapeutics, Inc
- Pharmacology Research Institute
- German Research Foundation
- British Columbia Cancer Agency
- Emory University
- Mclean Hospital
- The Mind Research Network
- University of Florida
- University of Arkansas
- Virginia Commonwealth University
- Wake Forest University
- University of Vermont
- Columbia University
- University of California, Los Angeles
- University of Cincinnati
- Vanderbilt University
- All India Institute of Medical Sciences
- Food and Drug Administration
- Chao Family Comprehensive Cancer Center
- Fletcher Allen Hospital
- University of Massachusetts
- State University of New York, Buffalo
- Stellenbosch University
- University of Duesseldorf
- +6 more
Organization Involved with Phase 1 Indications (13)
- Embera NeuroTherapeutics, Inc.
- Rock Creek Pharmaceuticals, Inc.
- Friends Research Institute, Inc.
- Case Western Reserve University
- Istituto Superiore di Sanità
- Kaiser Permanente
- University of Kentucky
- University of South Florida
- Canadian Institutes of Health Research (CIHR)
- Rose Research Center, LLC
- James and Esther King Biomedical Research Program
- Institut Hospital del Mar d'Investigacions Mèdiques
- BeiJing Hospital, No.1, Beijing, China.
Organization Involved with Other Experimental Indications (21)
- Shire
- Westat
- Eastern Cooperative Oncology Group
- Indiana University
- University of Kansas
- University of Medicine and Dentistry of New Jersey
- University of Miami
- University of Michigan
- University of Tennessee
- Wayne State University
- Tel Aviv University
- Hebrew University
- Pennsylvania State University
- University of Ostrava
- George Washington University
- Heffter Research Institute
- N.O.R.T.H., Inc.
- Beckley Foundation
- Canadian Psychiatric Research Foundation
- Juul
- Brainsway